Drug ID: | NPD3540 |
Drug Name: | Briciclib |
Molecular Formula: | C19H23O10PS |
Canonical SMILES: | COc1cc(OC)c(c(c1)OC)/C=C/S(=O)(=O)Cc1ccc(c(c1)OP(=O)(O)O)OC |
Standard InCHI: | InChI=1S/C19H23O10PS/c1-25-14-10-17(27-3)15(18(11-14)28-4)7-8-31(23,24)12-13-5-6-16(26-2)19(9-13)29-30(20,21)22/h5-11H,12H2,1-4H3,(H2,20,21,22)/b8-7+ |
Standard InCHIKey: | LXENKEWVEVKKGV-BQYQJAHWSA-N |
Max Developmental Stage: | Phase 1 |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB008181 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 474.07 |
ALogP | -1.0701 |
MLogP | 2.23 |
XLogP | 1.116 |
HDA | 5 |
HBD | 2 |
Rotatable Bonds | 16 |
TPSA | 156.01 |
RO5 Violation | 0 |